JİAN-XUN CHEN, LONG-BİN JENG, YU-SEN LİN, TİNG-YU LU, PEİ-YU KAO, HSİN-YUAN FANG
Experimental and Clinical Transplantation - 2016;14(5):571-574
Liver transplant is now considered to be a successful treatment modality for early hepatocellular car - cinoma. In addition, advances in immuno-suppressive therapy have greatly prolonged post-transplant survival of patients with hepatocellular carcinoma. However, both the posttransplant physiologic condition and immunosuppressive therapy affect the patient’s natural immunity, resulting in accumulating and more problematic complications. Three years after a male patient with hepatocellular carcinoma underwent living-donor liver transplant, he presented with esophageal metastasis from recurrence of hepatocellular carcinoma. This is an extremely rare complication, perhaps with an ominous prognosis, and, to the best of our knowledge, the first such case to be published in the English literature.
